Market Cap 1.15B
Revenue (ttm) 606.88M
Net Income (ttm) -225.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -37.19%
Debt to Equity Ratio 0.21
Volume 2,156,200
Avg Vol 2,845,114
Day's Range N/A - N/A
Shares Out 755.09M
Stochastic %K 66%
Beta 1.48
Analysts Sell
Price Target $2.38

Company Profile

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 305 575 4100
Address:
4400 Biscayne Boulevard, Miami, United States
BULLSWIN75
BULLSWIN75 Jul. 4 at 4:25 PM
$OPK Let’s play a little game here lol… my bet, OPKO will be 2.00+ by end of summer 👀
0 · Reply
Gasbagger
Gasbagger Jul. 3 at 5:12 PM
$OPK Tymtested and Bullswin havent posted yet today . Did Investor Relations give them a paid day off today??? They might post now,since I just called a spade a spade.
0 · Reply
tradertrash
tradertrash Jul. 3 at 4:07 PM
$OPK ok i'll play, let's just say the labs are GIANTLY successful just for the sake of argument, who doesn't think they aren't going to pay themselves and piss it all back thru r&d like they have been, its rite there in the history, rinse repeat, ur looking in the wrong place, its not about products and services being successful, ray and hgh are successful, u need a COMPLETE CHANGE OF BEHAVIOR... that's never going to happen imo
1 · Reply
Liorkd
Liorkd Jul. 3 at 9:54 AM
$OPK bio ref should break even or become profitable this quarter or the next quarter
1 · Reply
Gasbagger
Gasbagger Jul. 3 at 2:51 AM
$OPK When compared to peers like Quest Diagnostics and Labcorp, which are described as providing positive returns, OPKO's performance is exceptionally weak. These competitors have offered stability and big capital appreciation, while OPKO has delivered the opposite,year after year. The historical stock performance clearly reflects the market's negative verdict on the company's operational struggles, persistent unprofitability, and cash burn.
0 · Reply
BULLSWIN75
BULLSWIN75 Jul. 2 at 10:57 PM
$OPK 1.50’s is undervalued when you have the business assets they do. If desperate for cash, no way they sell-off lab segments to labCorp. They are trimming the fat, cleaning up balance sheet. Cash to debt ratio is very favorable. i think Frost retires within 12-24 months… 90 yr olds cant run companies effectively, just isnt ”the norm”. Wall St will like to see new blood run things here…
2 · Reply
Gasbagger
Gasbagger Jul. 2 at 9:16 PM
$OPK The same Posters that didnt talk about a Stock Chart when Opko was going dow , is now trying to Con woulkdbe buyers in with the Golden Cross Chart. It doesnt apply to Opko it never has.
0 · Reply
Gasbagger
Gasbagger Jul. 2 at 6:40 PM
$OPK This is Comical !!!!! A Committee that can APPOINT OTHERS TO DO THEIR JOB !!! The Succession Planning Committee shall be entitled to delegate any or all of its duties or responsibilities to a subcommittee of the Succession Planning Committee, to the extent consistent with the Company’s certificate of incorporation, bylaws, and applicable law and rules of markets in which the Company’s securities then trade.
0 · Reply
Liorkd
Liorkd Jul. 2 at 5:45 PM
$OPK yahoo finance 1y target est is 4.38
1 · Reply
Liorkd
Liorkd Jul. 2 at 5:44 PM
$OPK shares outstanding reduced to 746 million
0 · Reply
Latest News on OPK
OPKO Health Transcript: AGM 2026

Jun 18, 2026, 10:00 AM EDT - 16 days ago

OPKO Health Transcript: AGM 2026


OPKO Health Proxy statement: Proxy filing

May 15, 2026, 8:00 AM EDT - 7 weeks ago

OPKO Health Proxy statement: Proxy filing


OPKO Health Slides: Corporate presentation

May 8, 2026, 7:00 AM EDT - 2 months ago

OPKO Health Slides: Corporate presentation


OPKO Health Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

OPKO Health Proxy statement: Proxy filing


OPKO Health Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

OPKO Health Proxy statement: Proxy filing


OPKO Health Earnings Call Transcript: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 2 months ago

OPKO Health Earnings Call Transcript: Q1 2026


OPKO Health Earnings release: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 2 months ago

OPKO Health Earnings release: Q1 2026


OPKO Health Quarterly report: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 2 months ago

OPKO Health Quarterly report: Q1 2026


OPKO Health Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

OPKO Health Earnings Call Transcript: Q4 2025


OPKO Health Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

OPKO Health Annual report: Q4 2025


OPKO Health Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

OPKO Health Earnings release: Q4 2025


OPKO Health Slides: Corporate presentation

Nov 26, 2025, 7:00 AM EST - 7 months ago

OPKO Health Slides: Corporate presentation


Opko Health initiated with a Neutral at JPMorgan

2025-11-20T09:50:09.000Z - 8 months ago

Opko Health initiated with a Neutral at JPMorgan


Opko Health downgraded to Hold from Buy at Jefferies

2025-10-30T20:10:16.000Z - 8 months ago

Opko Health downgraded to Hold from Buy at Jefferies


Opko Health reports Q3 EPS 3c, consensus (5c)

2025-10-29T20:36:22.000Z - 8 months ago

Opko Health reports Q3 EPS 3c, consensus (5c)


OPKO Health Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

OPKO Health Earnings Call Transcript: Q3 2025


OPKO Health Quarterly report: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

OPKO Health Quarterly report: Q3 2025


OPKO Health Earnings release: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

OPKO Health Earnings release: Q3 2025


Opko Health’s ModeX Therapeutics begins trial of MDX2004

2025-10-28T12:21:29.000Z - 8 months ago

Opko Health’s ModeX Therapeutics begins trial of MDX2004


Opko Health management to meet with Barrington

2025-09-22T12:00:42.000Z - 10 months ago

Opko Health management to meet with Barrington


OPKO Health Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Earnings Call Transcript: Q2 2025


OPKO Health Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Quarterly report: Q2 2025


OPKO Health Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Earnings release: Q2 2025


NextPlat Issues Interim CEO Update Shareholder Letter

Jun 30, 2025, 8:01 AM EDT - 1 year ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL


Opko Health’s ModeX forms Scientific Advisory Board

2025-06-09T12:21:02.000Z - 1 year ago

Opko Health’s ModeX forms Scientific Advisory Board


OPKO Health Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Earnings Call Transcript: Q1 2025


OPKO Health Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Quarterly report: Q1 2025


OPKO Health Earnings release: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Earnings release: Q1 2025


Opko Health initiated with a Neutral at JPMorgan

2025-04-25T09:15:19.000Z - 1 year ago

Opko Health initiated with a Neutral at JPMorgan


Opko Health management to meet with Piper Sandler

2025-03-25T18:57:10.000Z - 1 year ago

Opko Health management to meet with Piper Sandler


OPKO and Entera partner to develop obesity pill

Mar 17, 2025, 8:57 AM EDT - 1 year ago

OPKO and Entera partner to develop obesity pill


OPKO Health Proxy statement: Proxy Filing

Mar 14, 2025, 8:00 AM EDT - 1 year ago

OPKO Health Proxy statement: Proxy Filing


OPKO Health Proxy statement: Proxy Filing

Mar 14, 2025, 8:00 AM EDT - 1 year ago

OPKO Health Proxy statement: Proxy Filing


OPKO Health Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

OPKO Health Earnings Call Transcript: Q4 2024


OPKO Health Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

OPKO Health Annual report: Q4 2024


OPKO Health Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

OPKO Health Earnings release: Q4 2024


OPKO Health Slides: FY 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

OPKO Health Slides: FY 2025


OPKO Health Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

OPKO Health Earnings Call Transcript: Q3 2024


OPKO Health Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

OPKO Health Quarterly report: Q3 2024


OPKO Health Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

OPKO Health Earnings release: Q3 2024


OPKO Health Proxy statement: Proxy Filing

Aug 30, 2024, 8:00 AM EDT - 2 years ago

OPKO Health Proxy statement: Proxy Filing


OPKO Health Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Earnings Call Transcript: Q2 2024


OPKO Health Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Quarterly report: Q2 2024


OPKO Health Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Earnings release: Q2 2024


OPKO Health Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Earnings Call Transcript: Q1 2024


OPKO Health Quarterly report: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Quarterly report: Q1 2024


OPKO Health Earnings release: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Earnings release: Q1 2024


OPKO Health Proxy statement: Proxy Filing

Feb 29, 2024, 7:00 AM EST - 2 years ago

OPKO Health Proxy statement: Proxy Filing


OPKO Health Earnings Call Transcript: Q4 2023

Feb 27, 2024, 4:30 PM EST - 2 years ago

OPKO Health Earnings Call Transcript: Q4 2023


OPKO Health Annual report: Q4 2023

Feb 27, 2024, 4:30 PM EST - 2 years ago

OPKO Health Annual report: Q4 2023


OPKO Health Earnings release: Q4 2023

Feb 27, 2024, 4:30 PM EST - 2 years ago

OPKO Health Earnings release: Q4 2023


OPKO Health Proxy statement: Proxy Filing

Feb 16, 2024, 7:00 AM EST - 2 years ago

OPKO Health Proxy statement: Proxy Filing


OPKO Health Earnings Call Transcript: Q3 2023

Nov 6, 2023, 4:30 PM EST - 2 years ago

OPKO Health Earnings Call Transcript: Q3 2023


OPKO Health Quarterly report: Q3 2023

Nov 6, 2023, 4:30 PM EST - 2 years ago

OPKO Health Quarterly report: Q3 2023


OPKO Health Earnings release: Q3 2023

Nov 6, 2023, 4:30 PM EST - 2 years ago

OPKO Health Earnings release: Q3 2023


OPKO Health Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

OPKO Health Earnings Call Transcript: Q2 2023


OPKO Health Quarterly report: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

OPKO Health Quarterly report: Q2 2023


OPKO Health Earnings release: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

OPKO Health Earnings release: Q2 2023


BULLSWIN75
BULLSWIN75 Jul. 4 at 4:25 PM
$OPK Let’s play a little game here lol… my bet, OPKO will be 2.00+ by end of summer 👀
0 · Reply
Gasbagger
Gasbagger Jul. 3 at 5:12 PM
$OPK Tymtested and Bullswin havent posted yet today . Did Investor Relations give them a paid day off today??? They might post now,since I just called a spade a spade.
0 · Reply
tradertrash
tradertrash Jul. 3 at 4:07 PM
$OPK ok i'll play, let's just say the labs are GIANTLY successful just for the sake of argument, who doesn't think they aren't going to pay themselves and piss it all back thru r&d like they have been, its rite there in the history, rinse repeat, ur looking in the wrong place, its not about products and services being successful, ray and hgh are successful, u need a COMPLETE CHANGE OF BEHAVIOR... that's never going to happen imo
1 · Reply
Liorkd
Liorkd Jul. 3 at 9:54 AM
$OPK bio ref should break even or become profitable this quarter or the next quarter
1 · Reply
Gasbagger
Gasbagger Jul. 3 at 2:51 AM
$OPK When compared to peers like Quest Diagnostics and Labcorp, which are described as providing positive returns, OPKO's performance is exceptionally weak. These competitors have offered stability and big capital appreciation, while OPKO has delivered the opposite,year after year. The historical stock performance clearly reflects the market's negative verdict on the company's operational struggles, persistent unprofitability, and cash burn.
0 · Reply
BULLSWIN75
BULLSWIN75 Jul. 2 at 10:57 PM
$OPK 1.50’s is undervalued when you have the business assets they do. If desperate for cash, no way they sell-off lab segments to labCorp. They are trimming the fat, cleaning up balance sheet. Cash to debt ratio is very favorable. i think Frost retires within 12-24 months… 90 yr olds cant run companies effectively, just isnt ”the norm”. Wall St will like to see new blood run things here…
2 · Reply
Gasbagger
Gasbagger Jul. 2 at 9:16 PM
$OPK The same Posters that didnt talk about a Stock Chart when Opko was going dow , is now trying to Con woulkdbe buyers in with the Golden Cross Chart. It doesnt apply to Opko it never has.
0 · Reply
Gasbagger
Gasbagger Jul. 2 at 6:40 PM
$OPK This is Comical !!!!! A Committee that can APPOINT OTHERS TO DO THEIR JOB !!! The Succession Planning Committee shall be entitled to delegate any or all of its duties or responsibilities to a subcommittee of the Succession Planning Committee, to the extent consistent with the Company’s certificate of incorporation, bylaws, and applicable law and rules of markets in which the Company’s securities then trade.
0 · Reply
Liorkd
Liorkd Jul. 2 at 5:45 PM
$OPK yahoo finance 1y target est is 4.38
1 · Reply
Liorkd
Liorkd Jul. 2 at 5:44 PM
$OPK shares outstanding reduced to 746 million
0 · Reply
Gasbagger
Gasbagger Jul. 2 at 4:07 PM
$OPK Buyers beware of tymtested. She just posted Opko hasnt had a secondary offerering in years.This is so far from truth. Opko redeemed a toxic Long Term Note last year and handed out over 250 million shares along with cash in exchange for the redemption.Shame on Tymtested she knows this to be a fact.
0 · Reply
Gasbagger
Gasbagger Jul. 2 at 4:02 PM
$OPK Frost just handed out over 3 million shares in stock options. The Stock Buyback is useless under certain scenarios, and this is one of them. Imagine buying back a million shares to only hand out 3 million in free shares.
0 · Reply
tradertrash
tradertrash Jul. 2 at 3:01 PM
$OPK ALWAYS TOMORROW heard that horsesh*t for years, not buying into that anymore, they should have been working for sh all along, not just taking care of themselves, if they would have tied compensation to stock performance that would have stopped the bs, that's never going to happen imo with them being majority sh, frostalicious being the majority sh was always a bad thing, a very very bad thing, like overpaying for commodeX rent, and the list goes on and on, just my thoughts and opinions as a long term sh
0 · Reply
tymtested
tymtested Jul. 2 at 2:30 PM
$OPK GOLDEN CROSS IS OCCURING TODAY!!!!
0 · Reply
tymtested
tymtested Jul. 2 at 11:05 AM
$OPK I do wish opko would stop increasing outstanding shares. Their stock buyback actions are not enough to offset the increase due ongoing compensation with shares, I suppose, because they haven’t had a secondary offering in years.
1 · Reply
BULLSWIN75
BULLSWIN75 Jul. 1 at 7:48 PM
$OPK fair value with current business isnt 1.50, it more like 2.50. So yes, this is undervalued. should only become more valuable as they decrease cap ex within lab space and increase revs on pharmaceuticals. 5 bucks EOY if they show strong turnaround in upcoming earnings reports (next is july 29)
0 · Reply
Gasbagger
Gasbagger Jul. 1 at 7:40 PM
$OPK Frost bought BRLI with Opko shares essentially planting the seeds for future revenues. ,profits and accelerating its future stock price. BRLI grew profits and revenues for over thirty years,before Opko bought it. Then under Frost ,the growth stopped and BRLI never earned a dime again. It just doesnt smell right. He then sells two thirds of BRLI for cash and doesnt share any of it with Shareholders. Why would anyone want to invest in Opko as long as Frost is in charge?
1 · Reply
tradertrash
tradertrash Jul. 1 at 3:13 PM
$OPK commodeX is frosty 2.0 imo, frosty showed them the way, take , don't deliver, rinse repeat
1 · Reply
Indyshaw
Indyshaw Jul. 1 at 2:27 PM
$ENTX $OPK if you’re following along on ENTX, check out its 2nd largest shareholder and enjoy both ENTX and OPKO. Bright futures for both.
1 · Reply
tymtested
tymtested Jul. 1 at 11:19 AM
$OPK Dr frost brought in ModeX, drove collaborations, essentially planting all the seeds for our coming harvest of earnings, profits and accelerating stock price. Criticisms arise from fast buck investors. Unfortunately frost has misjudged the potential of some of the projects but he hasn’t given up and opko future is looking brighter than ever.
0 · Reply
BULLSWIN75
BULLSWIN75 Jul. 1 at 11:06 AM
$OPK Alot of talk around CEO Frost on this forum. One thing for certain, historically he hasnt delivered value, so yes very true. But lately making smarter moves to clean up balance sheet. lets also consider this man is 90. i dont think he’ll he in that role for much longer…. how many CEO’s do you know about who are in their 90’s ???? probably none..
0 · Reply
Tbickle
Tbickle Jul. 1 at 2:00 AM
$OPK Phil freakin Frost doesnt deliver
1 · Reply